{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:40:53Z","timestamp":1791330053126,"version":"4.3.1"},"reference-count":169,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T00:00:00Z","timestamp":1643846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"abstract":"<jats:p>Human immunodeficiency virus, hepatitis B virus, and hepatitis C virus are three blood-borne viruses that can cause major global health issues by increasing severe morbidity. There is a high risk of coinfection with these viruses in individuals because of their same transmission routes through blood using shared needles, syringes, other injection equipment, sexual transmission, or even vertical transmission. Coinfection can cause various liver-related illnesses, non-hepatic organ dysfunction, followed by death compared to any of these single infections. The treatment of coinfected patients is complicated due to the side effects of antiviral medication, resulting in drug resistance, hepatotoxicity, and a lack of required responses. On the other hand, coinfected individuals must be treated with multiple drugs simultaneously, such as for HIV either along with HBV or HCV and HBV and HCV. Therefore, diagnosing, treating, and controlling dual infections with HIV, HBV, or HCV is complicated and needs further investigation. This review focuses on the current prevalence, risk factors, and pathogenesis of dual infections with HIV, HBV, and HCV. We also briefly overviewed the diagnosis and treatment of coinfections of these three blood-borne viruses.<\/jats:p>","DOI":"10.3389\/fmicb.2021.780887","type":"journal-article","created":{"date-parts":[[2022,2,3]],"date-time":"2022-02-03T08:37:40Z","timestamp":1643877460000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":55,"title":["Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment"],"prefix":"10.3389","volume":"12","author":[{"given":"Sagarika","family":"Shahriar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusha","family":"Araf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasel","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pravakar","family":"Kattel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganga Sagar","family":"Sah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanjim Ishraq","family":"Rahaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahila Zannat","family":"Sadiea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahnaj","family":"Sultana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Sayeedul","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md. Golzar","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,2,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1159\/000110407","article-title":"Sexually transmitted infections, sexual risk behaviors and the risk of heterosexual spread of HIV among and beyond IDUs in St. Petersburg, Russia.","volume":"14","author":"Abdala","year":"2008","journal-title":"Eur. Addict. Res."},{"key":"B2","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1056\/NEJMoa1316366","article-title":"Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection.","volume":"370","author":"Afdhal","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1468-1293.2005.00330.x","article-title":"Validation of a simple model for predicting liver fibrosis in HIV\/hepatitis C virus-coinfected patients.","volume":"6","author":"Al-Mohri","year":"2005","journal-title":"HIV Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1016\/j.jhep.2005.11.004","article-title":"Epidemiology of viral hepatitis and HIV co-infection.","volume":"44","author":"Alter","year":"2006","journal-title":"J. Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1097\/01.tp.0000161250.83392.73","article-title":"Natural history of hepatitis B and C in renal allograft recipients.","volume":"79","author":"Aroldi","year":"2005","journal-title":"Transplantation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/QAI.0000000000002386","article-title":"Long-term TDF-inclusive ART and progressive rates of HBsAg loss in HIV-HBV coinfection-lessons for functional HBV cure?","volume":"84","author":"Audsley","year":"2020","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0151946","article-title":"HIV, HBV and HCV coinfection prevalence in Iran\u2013a systematic review and meta-analysis.","volume":"11","author":"Bagheri Amiri","year":"2016","journal-title":"PLoS One"},{"key":"B8","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1128\/JVI.68.8.5045-5055.1994","article-title":"Kinetic and structural analyses of hepatitis C virus polyprotein processing.","volume":"68","author":"Bartenschlager","year":"1994","journal-title":"J. Virol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1002\/hep.21321","article-title":"Hepatitis C virus entry: molecular biology and clinical implications.","volume":"44","author":"Barth","year":"2006","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1111\/j.1468-1293.2009.00815.x","article-title":"Hepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patients.","volume":"11","author":"Bedimo","year":"2010","journal-title":"HIV Med."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1002\/hep.510300525","article-title":"Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients.","volume":"30","author":"Benhamou","year":"1999","journal-title":"Hepatology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/9241679","article-title":"Epidemiological profile and risk factors for acquiring HBV and\/or HCV in HIV-infected population groups in Nepal.","volume":"2018","author":"Bhattarai","year":"2018","journal-title":"Biomed Res. Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3390\/idr13010011","article-title":"Frequency of hepatitis B, C and HIV infections among transfusion-dependent beta thalassemia patients in Dhaka.","volume":"13","author":"Bhuyan","year":"2021","journal-title":"Infect. Dis. Rep."},{"key":"B14","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1056\/NEJM198703053161015","article-title":"Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV.","volume":"316","author":"Biggar","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"B15","first-page":"154","article-title":"The new EASL guidelines for the management of chronic hepatitis B infection adapted for Swiss physicians.","volume":"140","author":"Bihl","year":"2010","journal-title":"Swiss Med. Wkly."},{"key":"B16","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1128\/JVI.00024-06","article-title":"Hepatitis C virus entry depends on clathrin-mediated endocytosis.","volume":"80","author":"Blanchard","year":"2006","journal-title":"J. Virol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1093\/infdis\/163.5.1138","article-title":"The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state.","volume":"163","author":"Bodsworth","year":"1991","journal-title":"J. Infect. Dis."},{"key":"B18","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/0042-6822(88)90518-1","article-title":"The duck hepatitis B virus P-gene codes for protein strongly associated with the 5\u2019-end of the viral DNA minus strand.","volume":"166","author":"Bosch","year":"1988","journal-title":"Virology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1111\/jvh.12581","article-title":"Intensification with pegylated interferon during treatment with tenofovir in HIV-hepatitis B virus co-infected patients.","volume":"23","author":"Boyd","year":"2016","journal-title":"J. Viral Hepat."},{"key":"B20","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1053\/jhep.2001.25172","article-title":"Persistent hepatitis B virus infection in subjects without hepatitis B surface antigen: clinically significant or purely \u201coccult\u201d?","volume":"34","author":"Br\u00e9chot","year":"2001","journal-title":"Hepatology"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/s12954-017-0172-z","article-title":"Hepatitis C bio-behavioural surveys in people who inject drugs-a systematic review of sensitivity to the theoretical assumptions of respondent driven sampling.","volume":"14","author":"Buchanan","year":"2017","journal-title":"Harm Reduct. J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"8239","DOI":"10.1073\/pnas.91.17.8239","article-title":"Sequence analysis of the core gene of 14 hepatitis C virus genotypes.","volume":"91","author":"Bukh","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/jvh.12754","article-title":"HBV reactivation in patients with HCV\/HBV cirrhosis on treatment with direct-acting antivirals.","volume":"25","author":"Calvaruso","year":"2018","journal-title":"J. Viral Hepat."},{"key":"B24","first-page":"183","article-title":"Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: a study from tertiary care hospital.","volume":"26","author":"Chakravarti","year":"2005","journal-title":"Trop. Gastroenterol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1097\/QAD.0b013e3283292195","article-title":"Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.","volume":"23","author":"Collin","year":"2009","journal-title":"AIDS"},{"key":"B26","first-page":"1147","article-title":"Prevalence and significance of hepatitis C viremia in chronic active hepatitis B.","volume":"89","author":"Crespo","year":"1994","journal-title":"Am. J. Gastroenterol."},{"key":"B27","doi-asserted-by":"crossref","DOI":"10.1186\/1476-0711-4-13","article-title":"Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection.","volume":"4","author":"Crockett","year":"2005","journal-title":"Ann. Clin. Microbiol. Antimicrob."},{"key":"B28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/hep.1840130122","article-title":"Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis.","volume":"13","author":"Davies","year":"1991","journal-title":"Hepatology"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1016\/0016-5085(92)91188-a","article-title":"Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver.","volume":"103","author":"de Jongh","year":"1992","journal-title":"Gastroenterology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1053\/jhep.2001.29201","article-title":"The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study.","volume":"34","author":"Di Martino","year":"2001","journal-title":"Hepatology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1053\/gast.2002.37061","article-title":"Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B.","volume":"123","author":"Di Martino","year":"2002","journal-title":"Gastroenterology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1086\/314942","article-title":"Dual efficacy of lamivudine treatment in human immunodeficiency virus\/hepatitis B virus-coinfected persons in a randomized, controlled study (CAESAR). The CAESAR Coordinating Committee.","volume":"180","author":"Dore","year":"1999","journal-title":"J. Infect. Dis."},{"key":"B33","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1016\/j.jhep.2014.06.031","article-title":"Virology and cell biology of the hepatitis C virus life cycle: an update.","volume":"61","author":"Dubuisson","year":"2014","journal-title":"J. Hepatol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1055\/s-0032-1316476","article-title":"Challenges and priorities in the management of HIV\/HBV and HIV\/HCV coinfection in resource-limited settings.","volume":"32","author":"Easterbrook","year":"2012","journal-title":"Semin. Liver Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1128\/jvi.76.12.5974-5984.2002","article-title":"Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex.","volume":"76","author":"Egger","year":"2002","journal-title":"J. Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2761","DOI":"10.1099\/vir.0.19305-0","article-title":"Replication of hepatitis C virus RNA occurs in a membrane-bound replication complex containing nonstructural viral proteins and RNA.","volume":"84","author":"El-Hage","year":"2003","journal-title":"J. Gen. Virol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1097\/00002030-199206000-00008","article-title":"Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS.","volume":"6","author":"Eskild","year":"1992","journal-title":"AIDS"},{"key":"B38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection.","volume":"57","year":"2012","journal-title":"J. Hepatol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"764","DOI":"10.7326\/0003-4819-115-10-764","article-title":"Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV).","volume":"115","author":"Eyster","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1071\/SH10163","article-title":"Liver disease, HIV and aging.","volume":"8","author":"Falade-Nwulia","year":"2011","journal-title":"Sex. Health"},{"key":"B41","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.3748\/wjg.v9.i9.2012","article-title":"Spontaneous viral clearance after 6-21 years of hepatitis B and C viruses coinfection in high HBV endemic area.","volume":"9","author":"Fan","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/j.1600-0676.1990.tb00449.x","article-title":"Spontaneous reactivation of hepatitis B virus infection in patients with chronic type B hepatitis.","volume":"10","author":"Fattovich","year":"1990","journal-title":"Liver"},{"key":"B43","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1136\/gut.32.3.294","article-title":"Natural history and prognostic factors for chronic hepatitis type B.","volume":"32","author":"Fattovich","year":"1991","journal-title":"Gut"},{"key":"B44","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/hep.1840060203","article-title":"Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B.","volume":"6","author":"Fattovich","year":"1986","journal-title":"Hepatology"},{"key":"B45","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/cid\/cis1206","article-title":"Rapid progression to decompensated cirrhosis, liver transplant, and death in HIV-infected men after primary hepatitis C virus infection.","volume":"56","author":"Fierer","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e202","DOI":"10.1111\/j.1365-2893.2011.01529.x","article-title":"The association of HIV viral load with indirect markers of liver injury.","volume":"19","author":"Forrester","year":"2012","journal-title":"J. Viral Hepat."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1086\/429302","article-title":"Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: implications for hepatitis B vaccine strategies.","volume":"191","author":"Gandhi","year":"2005","journal-title":"J. Infect. Dis."},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofu052.1134","article-title":"1588: Prevalence of and factors associated with hepatitis C virus testing and infection among HIV-infected adults receiving medical care in the United States.","author":"Garg","year":"2014","journal-title":"Open Forum Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/00002030-199705000-00007","article-title":"Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection.","volume":"11","author":"Gilson","year":"1997","journal-title":"AIDS"},{"key":"B50","doi-asserted-by":"publisher","first-page":"5487","DOI":"10.1128\/jvi.77.9.5487-5492.2003","article-title":"Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons.","volume":"77","author":"Gosert","year":"2003","journal-title":"J. Virol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1097\/01.aids.0000171412.61360.f8","article-title":"A cluster of acute hepatitis C virus infection among men who have sex with men\u2013results from contact tracing and public health implications.","volume":"19","author":"G\u00f6tz","year":"2005","journal-title":"AIDS"},{"key":"B52","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.3748\/wjg.v22.i6.1953","article-title":"Hepatitis C virus relies on lipoproteins for its life cycle.","volume":"22","author":"Grassi","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"B53","doi-asserted-by":"crossref","DOI":"10.4081\/idr.2013.s1.e7","article-title":"Hepatitis C virus and HIV type 1 co-infection.","volume":"5","author":"Gupta","year":"2013","journal-title":"Infect. Dis. Rep."},{"key":"B54","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1056\/NEJMoa021812","article-title":"Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B.","volume":"348","author":"Hadziyannis","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"B55","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1093\/jac\/dkw203","article-title":"High rates of hepatitis C virus (HCV) cure using direct-acting antivirals in HIV\/HCV-coinfected patients: a real-world perspective.","volume":"71","author":"Hawkins","year":"2016","journal-title":"J. Antimicrob. Chemother."},{"key":"B56","year":"2014","journal-title":"The Role of Policy, Advocacy, Governance, and Financing in Addressing the HIV Epidemic [Online]."},{"key":"B57","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00018-007-7291-8","article-title":"Hepatitis C virus entry into host cells.","volume":"65","author":"Helle","year":"2008","journal-title":"Cell. Mol. Life Sci."},{"key":"B58","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1097\/COH.0b013e32834bd365","article-title":"HIV\/hepatitis C coinfection natural history and disease progression.","volume":"6","author":"Hernandez","year":"2011","journal-title":"Curr. Opin. HIV AIDS"},{"key":"B59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1055\/s-2008-1040426","article-title":"Serologic diagnosis of acute and chronic viral hepatitis.","volume":"11","author":"Hoofnagle","year":"1991","journal-title":"Semin. Liver Dis."},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.3390\/v12020175","article-title":"Impact of the interaction of hepatitis B virus with mitochondria and associated proteins.","volume":"12","author":"Hossain","year":"2020","journal-title":"Viruses"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0167871","article-title":"Investigation of a novel hepatitis B virus surface antigen (HBsAg) escape mutant affecting immunogenicity.","volume":"12","author":"Hossain","year":"2017","journal-title":"PLoS One"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1016\/S0140-6736(00)04258-6","article-title":"Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.","volume":"357","author":"Imbert-Bismut","year":"2001","journal-title":"Lancet"},{"key":"B63","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/S0140-6736(14)60494-3","article-title":"Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial.","volume":"384","author":"Jacobson","year":"2014","journal-title":"Lancet"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043143","article-title":"Hepatitis B surface antigen concentrations in patients with HIV\/HBV co-infection.","volume":"7","author":"Jaroszewicz","year":"2012","journal-title":"PLoS One"},{"key":"B65","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1310\/hct0803-173","article-title":"Safety and tolerability of sequential pegylated IFN-alpha2a and tenofovir for hepatitis B infection in HIV(+) individuals.","volume":"8","author":"Johnson","year":"2007","journal-title":"HIV Clin. Trials"},{"key":"B66","doi-asserted-by":"publisher","first-page":"4018","DOI":"10.2174\/092986710793205354","article-title":"Glycosaminoglycans as key molecules in atherosclerosis: the role of versican and hyaluronan.","volume":"17","author":"Karangelis","year":"2010","journal-title":"Curr. Med. Chem."},{"key":"B67","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1089\/omi.1.2000.5.129","article-title":"Genome of human hepatitis C virus (HCV): gene organization, sequence diversity, and variation.","volume":"5","author":"Kato","year":"2000","journal-title":"Microb. Comp. Genomics"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/4239646","article-title":"Hepatitis B virus infection in Tanzania: current status and challenges.","volume":"2018","author":"Kilonzo","year":"2018","journal-title":"J. Trop. Med."},{"key":"B69","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1053\/j.gastro.2009.06.040","article-title":"Coinfection with HIV-1 and HCV\u2013a one-two punch.","volume":"137","author":"Kim","year":"2009","journal-title":"Gastroenterology"},{"key":"B70","first-page":"263","article-title":"Human immunodeficiency virus and hepatitis B and C coinfection: pathogenic interactions, natural history, and therapy.","volume":"12","author":"Kim","year":"2000","journal-title":"IDS Clin. Rev."},{"key":"B71","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/s0140-6736(87)91725-9","article-title":"Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study.","volume":"1","author":"Kingsley","year":"1987","journal-title":"Lancet"},{"key":"B72","doi-asserted-by":"publisher","first-page":"658","DOI":"10.7326\/0003-4819-158-9-201305070-00604","article-title":"HIV, age, and the severity of hepatitis C virus-related liver disease: a cohort study.","volume":"158","author":"Kirk","year":"2013","journal-title":"Ann. Intern. Med."},{"key":"B73","first-page":"221","article-title":"The spectrum of HBV\/HCV coinfection: epidemiology, clinical characteristics, viralinteractions and management.","volume":"28","author":"Konstantinou","year":"2015","journal-title":"Ann. Gastroenterol."},{"key":"B74","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1042\/CS20080532","article-title":"Effects of HCV co-infection on apoptosis of CD4+ T-cells in HIV-positive patients.","volume":"116","author":"K\u00f6rner","year":"2009","journal-title":"Clin. Sci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1086\/650997","article-title":"Activation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virus.","volume":"201","author":"Kovacs","year":"2010","journal-title":"J. Infect. Dis."},{"key":"B76","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.jhep.2020.11.021","article-title":"Clinical outcomes following DAA therapy in patients with HCV-related cirrhosis depend on disease severity.","volume":"74","author":"Krassenburg","year":"2021","journal-title":"J. Hepatol."},{"key":"B77","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1086\/520092","article-title":"Hepatotoxicity of antiretroviral drugs is reduced after successful treatment of chronic hepatitis C in HIV-infected patients.","volume":"196","author":"Labarga","year":"2007","journal-title":"J. Infect. Dis."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1002\/hep.20717","article-title":"Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.","volume":"41","author":"Lackner","year":"2005","journal-title":"Hepatology"},{"key":"B79","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/135965350400900311","article-title":"In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.","volume":"9","author":"Lada","year":"2004","journal-title":"Antivir. Ther."},{"key":"B80","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0929-6646(08)60106-0","article-title":"Seroprevalence of viral hepatitis and sexually transmitted disease among adults with recently diagnosed HIV infection in Southern Taiwan, 2000-2005: upsurge in hepatitis C virus infections among injection drug users.","volume":"107","author":"Lee","year":"2008","journal-title":"J. Formos. Med. Assoc."},{"key":"B81","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1146\/annurev-cellbio-100814-125241","article-title":"The hepatitis B virus receptor.","volume":"31","author":"Li","year":"2015","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"B82","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/hep.1840080310","article-title":"The development of cirrhosis in patients with chronic type B hepatitis: a prospective study.","volume":"8","author":"Liaw","year":"1988","journal-title":"Hepatology"},{"key":"B83","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1001\/archinte.166.1.49","article-title":"A double-blind placebo-controlled study of emtricitabine in chronic hepatitis B.","volume":"166","author":"Lim","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"B84","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/jgh.12421","article-title":"Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues.","volume":"29","author":"Liu","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1136\/gutjnl-2012-304370","article-title":"Treatment of patients with dual hepatitis C and B by peginterferon \u03b1 and ribavirin reduced risk of hepatocellular carcinoma and mortality.","volume":"63","author":"Liu","year":"2014","journal-title":"Gut"},{"key":"B86","doi-asserted-by":"publisher","first-page":"369","DOI":"10.7326\/M13-1829","article-title":"Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.","volume":"160","author":"Lo Re","year":"2014","journal-title":"Ann. Intern. Med."},{"key":"B87","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009.","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"B88","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1128\/CMR.12.2.351","article-title":"Update on diagnosis, management, and prevention of hepatitis B virus infection.","volume":"12","author":"Mahoney","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-020-01372-2","article-title":"Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIV.","volume":"20","author":"Maponga","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"B90","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1097\/QAI.0b013e3181b79aff","article-title":"Risk factors for thrombocytopenia in HIV-infected persons in the era of potent antiretroviral therapy.","volume":"52","author":"Marks","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"B91","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1016\/0016-5085(89)90405-8","article-title":"Rapidly progressive non-A, non-B hepatitis in patients with human immunodeficiency virus infection.","volume":"97","author":"Martin","year":"1989","journal-title":"Gastroenterology"},{"key":"B92","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1086\/367643","article-title":"Progression of chronic hepatitis C to liver fibrosis and cirrhosis in patients coinfected with hepatitis C virus and human immunodeficiency virus.","volume":"36","author":"Martinez-Sierra","year":"2003","journal-title":"Clin. Infect. Dis."},{"key":"B93","doi-asserted-by":"publisher","first-page":"759","DOI":"10.7326\/0003-4819-135-9-200111060-00006","article-title":"Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus.","volume":"135","author":"McMahon","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"B94","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ajg.2013.11.003","article-title":"Virologic and histologic characterisation of dual hepatitis B and C co-infection in Egyptian patients.","volume":"14","author":"Mekky","year":"2013","journal-title":"Arab J. Gastroenterol."},{"key":"B95","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/hep.27259","article-title":"Global distribution and prevalence of hepatitis C virus genotypes.","volume":"61","author":"Messina","year":"2015","journal-title":"Hepatology"},{"key":"B96","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1086\/520752","article-title":"Impact of highly active antiretroviral therapy (HAART) on the natural history of hepatitis B virus (HBV) and HIV coinfection: relationship between prolonged efficacy of HAART and HBV surface and early antigen seroconversion.","volume":"45","author":"Miailhes","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B97","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1136\/bmj.307.6912.1095","article-title":"Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection.","volume":"307","author":"Mimms","year":"1993","journal-title":"BMJ"},{"key":"B98","first-page":"588","article-title":"Fibrotest-Actitest: the biochemical marker of liver fibrosis\u2013the Israeli experience.","volume":"9","author":"Morali","year":"2007","journal-title":"Isr. Med. Assoc. J."},{"key":"B99","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1365-2893.2009.01088.x","article-title":"Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV\/HBV co-infection.","volume":"16","author":"Moreno","year":"2009","journal-title":"J. Viral Hepat."},{"key":"B100","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa1501315","article-title":"Ledipasvir and sofosbuvir for HCV in patients coinfected with HIV-1.","volume":"373","author":"Naggie","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3390\/tropicalmed6030150","article-title":"The effect of HBV\/HCV in response to HAART in HIV patients after 12 months in Kumba Health District in the South West Region of Cameroon.","volume":"6","author":"Ndifontiayong","year":"2021","journal-title":"Trop. Med. Infect. Dis."},{"key":"B102","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1002\/hep.24308","article-title":"Ethnic differences in viral dominance patterns in patients with hepatitis B virus and hepatitis C virus dual infection.","volume":"53","author":"Nguyen","year":"2011","journal-title":"Hepatology"},{"key":"B103","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jinf.2008.05.004","article-title":"Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi.","volume":"57","author":"Nyirenda","year":"2008","journal-title":"J. Infect."},{"key":"B104","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/s0168-8278(97)80274-7","article-title":"Hepatitis B and C in HIV-infected patients. Prevalence and prognostic value.","volume":"27","author":"Ockenga","year":"1997","journal-title":"J. Hepatol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/s0168-8278(94)80094-4","article-title":"Hepatitis C virus antibody and hepatitis C virus replication in chronic hepatitis B patients.","volume":"21","author":"Ohkawa","year":"1994","journal-title":"J. Hepatol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11904-010-0071-3","article-title":"HIV\/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies.","volume":"8","author":"Operskalski","year":"2011","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"B107","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.vaccine.2011.12.116","article-title":"Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.","volume":"30","author":"Ott","year":"2012","journal-title":"Vaccine"},{"key":"B108","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1023\/a:1007619614350","article-title":"Coinfections by HIV, hepatitis B and hepatitis C in imprisoned injecting drug users.","volume":"15","author":"Pall\u00e1s","year":"1999","journal-title":"Eur. J. Epidemiol."},{"key":"B109","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1002\/jmv.1890440211","article-title":"Diagnosis of hepatitis C virus-associated chronic liver disease in India: comparison of HCV antibody assay with a polymerase chain reaction for the 5\u2019 noncoding region.","volume":"44","author":"Panigrahi","year":"1994","journal-title":"J. Med. Virol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1097\/qad.0b013e328329f994","article-title":"HAART is associated with lower hepatic necroinflammatory activity in HIV-hepatitis C virus-coinfected patients with CD4 cell count of more than 350 cells\/microl at the time of liver biopsy.","volume":"23","author":"Pascual-Pareja","year":"2009","journal-title":"AIDS"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1053\/j.gastro.2014.03.003","article-title":"New hepatitis C therapies: the toolbox, strategies, and challenges.","volume":"146","author":"Pawlotsky","year":"2014","journal-title":"Gastroenterology"},{"key":"B112","doi-asserted-by":"publisher","first-page":"40835","DOI":"10.1074\/jbc.M404761200","article-title":"Structure and function of the membrane anchor domain of hepatitis C virus nonstructural protein 5A.","volume":"279","author":"Penin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B113","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1097\/QAD.0b013e32830b3ab5","article-title":"Efficacy and safety of entecavir for chronic HBV in HIV\/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.","volume":"22","author":"Pess\u00f4a","year":"2008","journal-title":"AIDS"},{"key":"B114","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/rmv.1890","article-title":"Prevention strategies for blood-borne viruses-in the era of vaccines, direct acting antivirals and antiretroviral therapy.","volume":"26","author":"Pfaender","year":"2016","journal-title":"Rev. Med. Virol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.jhep.2014.04.041","article-title":"Hepatitis B virus PreS\/S gene variants: pathobiology and clinical implications.","volume":"61","author":"Pollicino","year":"2014","journal-title":"J. Hepatol."},{"key":"B116","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1056\/NEJMoa1402869","article-title":"ABT-450\/r-ombitasvir and dasabuvir with ribavirin for hepatitis C with cirrhosis.","volume":"370","author":"Poordad","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"B117","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.83704","article-title":"Coinfection of hepatitis B and C in HIV patients: a review of the state of the art","author":"Porras-Ram\u00edrez","year":"2020","journal-title":"Hepatitis B and C"},{"key":"B118","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1128\/CMR.00015-09","article-title":"Immune restoration diseases reflect diverse immunopathological mechanisms.","volume":"22","author":"Price","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"B119","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1086\/317644","article-title":"Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus.","volume":"183","author":"Puoti","year":"2001","journal-title":"J. Infect. Dis."},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-015-2003-z","article-title":"HIV, hepatitis B and C among people who inject drugs: high prevalence of HIV and Hepatitis C RNA positive infections observed in Delhi, India.","volume":"15","author":"Ray Saraswati","year":"2015","journal-title":"BMC Public Health"},{"key":"B121","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4103\/0255-0857.13872","article-title":"Prevalence of HBV and HCV dual infection in patients on haemodialysis.","volume":"23","author":"Reddy","year":"2005","journal-title":"Indian J. Med. Microbiol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"4127","DOI":"10.1128\/JVI.69.7.4127-4136.1995","article-title":"Hepatitis C virus-encoded NS2-3 protease: cleavage-site mutagenesis and requirements for bimolecular cleavage.","volume":"69","author":"Reed","year":"1995","journal-title":"J. Virol."},{"key":"B123","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.77706","author":"Rodrigo","year":"2020","journal-title":"Hepatitis B and C."},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/196704","article-title":"Safety and efficacy of hepatitis B vaccination in cirrhosis of liver.","volume":"2013","author":"Roni","year":"2013","journal-title":"Adv. Virol."},{"key":"B125","doi-asserted-by":"publisher","first-page":"7366","DOI":"10.1128\/JVI.00191-09","article-title":"Coinfection with hepatitis C virus and human immunodeficiency virus: virological, immunological, and clinical outcomes.","volume":"83","author":"Rotman","year":"2009","journal-title":"J. Virol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1086\/498348","article-title":"Emtricitabine, a new antiretroviral agent with activity against HIV and hepatitis B virus.","volume":"42","author":"Saag","year":"2006","journal-title":"Clin. Infect. Dis."},{"key":"B127","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3748\/wjg.v13.i1.14","article-title":"Hepatitis B virus taxonomy and hepatitis B virus genotypes.","volume":"13","author":"Schaefer","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"B128","first-page":"20","article-title":"Hepatitis B\/C virus co-infection in Iran: a seroepidemiological study.","volume":"18","author":"Semnani","year":"2007","journal-title":"Turk. J. Gastroenterol."},{"key":"B129","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S1665-2681(19)31887-3","article-title":"Clinicopathologic features of dual chronic hepatitis B and C infection: a comparison with single hepatitis B, C and delta infections.","volume":"7","author":"Senturk","year":"2008","journal-title":"Ann. Hepatol."},{"key":"B130","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.trsl.2015.07.010","article-title":"Therapeutics targeting inflammation in the immune reconstitution inflammatory syndrome.","volume":"167","author":"Shahani","year":"2016","journal-title":"Transl. Res."},{"key":"B131","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/s0376-8716(06)80006-2","article-title":"Risk behaviors and HIV, hepatitis B, and hepatitis C seroprevalence among injection drug users in Georgia.","author":"Shapatava","year":"2006","journal-title":"Drug Alcohol Depend."},{"key":"B132","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1086\/339042","article-title":"Hepatitis C virus prevalence among patients infected with human immunodeficiency virus: a cross-sectional analysis of the US adult AIDS Clinical Trials Group.","volume":"34","author":"Sherman","year":"2002","journal-title":"Clin. Infect. Dis."},{"key":"B133","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1097\/QAI.0b013e31802e29a9","article-title":"The prevalence and significance of occult hepatitis B virus in a prospective cohort of HIV-infected patients.","volume":"44","author":"Shire","year":"2007","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"B134","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/0966-842x(96)81501-0","article-title":"M cells and the pathogenesis of mucosal and systemic infections.","volume":"4","author":"Siebers","year":"1996","journal-title":"Trends Microbiol."},{"key":"B135","doi-asserted-by":"publisher","first-page":"3713","DOI":"10.3748\/wjg.15.3713","article-title":"Management of hepatitis C virus infection in HIV\/HCV co-infected patients: clinical review.","volume":"15","author":"Singal","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"B136","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1111\/j.1365-2036.2009.04062.x","article-title":"Systematic review: non-invasive methods of fibrosis analysis in chronic hepatitis C.","volume":"30","author":"Smith","year":"2009","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B137","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1097\/QAD.0b013e3281084e4d","article-title":"Care of patients coinfected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel.","volume":"21","author":"Soriano","year":"2007","journal-title":"AIDS"},{"key":"B138","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1365-2893.2009.01249.x","article-title":"Prevalence of chronic hepatitis B virus infection among patients in the HIV outpatient study, 1996-2007.","volume":"17","author":"Spradling","year":"2010","journal-title":"J. Viral Hepat."},{"key":"B139","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1055\/s-2004-832930","article-title":"Hepatitis C virus in the setting of HIV or hepatitis B virus coinfection.","author":"Sterling","year":"2004","journal-title":"Semin. Liver Dis."},{"key":"B140","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1007\/BF02773887","article-title":"The development of hepatocellular carcinoma from liver cirrhosis during a follow-up study.","volume":"24","author":"Sulaiman","year":"1989","journal-title":"Gastroenterol. Jpn."},{"key":"B141","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/BF03160472","article-title":"Hepatitis C virus infection in HIV-infected patients.","volume":"3","author":"Sulkowski","year":"2001","journal-title":"Curr. Infect. Dis. Rep."},{"key":"B142","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1001\/jama.2015.1328","article-title":"Ombitasvir, paritaprevir co-dosed with ritonavir, dasabuvir, and ribavirin for hepatitis C in patients co-infected with HIV-1: a randomized trial.","volume":"313","author":"Sulkowski","year":"2015","journal-title":"JAMA"},{"key":"B143","doi-asserted-by":"publisher","first-page":"14598","DOI":"10.3748\/wjg.v20.i40.14598","article-title":"Hepatitis B virus coinfection in human immunodeficiency virus-infected patients: a review.","volume":"20","author":"Sun","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"B144","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.tem.2009.07.005","article-title":"Hepatitis C virus hijacks host lipid metabolism.","volume":"21","author":"Syed","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"B145","doi-asserted-by":"publisher","first-page":"3498","DOI":"10.1128\/AAC.48.9.3498-3507.2004","article-title":"Clinical emergence of entecavir-resistant hepatitis B virus requires additional substitutions in virus already resistant to lamivudine.","volume":"48","author":"Tenney","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B146","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1097\/QAD.0b013e32830e6d51","article-title":"Natural history of hepatitis C virus infection in HIV-infected individuals and the impact of HIV in the era of highly active antiretroviral therapy: a meta-analysis.","volume":"22","author":"Thein","year":"2008","journal-title":"AIDS"},{"key":"B147","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jhep.2005.10.012","article-title":"Treatment of lamivudine-resistant hepatitis B in HIV-infected persons: is adefovir dipivoxil the answer?","volume":"44","author":"Thio","year":"2006","journal-title":"J. Hepatol."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1016\/s0140-6736(02)11913-1","article-title":"HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS).","volume":"360","author":"Thio","year":"2002","journal-title":"Lancet"},{"key":"B149","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1001\/jama.284.4.450","article-title":"The natural history of hepatitis C virus infection: host, viral, and environmental factors.","volume":"284","author":"Thomas","year":"2000","journal-title":"JAMA"},{"key":"B150","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1093\/infdis\/171.4.768","article-title":"Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore\u2013an analysis of 309 sex partnerships.","volume":"171","author":"Thomas","year":"1995","journal-title":"J. Infect. Dis."},{"key":"B151","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/j.1365-2893.2009.01102.x","article-title":"Inhibition of intracellular hepatitis C virus replication by nelfinavir and synergistic effect with interferon-alpha.","volume":"16","author":"Toma","year":"2009","journal-title":"J. Viral Hepat."},{"key":"B152","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1086\/520989","article-title":"Prevalence and long-term effects of occult hepatitis B virus infection in HIV-infected women.","volume":"45","author":"Tsui","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B153","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1002\/hep.23679","article-title":"Human immunodeficiency virus (HIV)-1 infects human hepatic stellate cells and promotes collagen I and monocyte chemoattractant protein-1 expression: implications for the pathogenesis of HIV\/hepatitis C virus-induced liver fibrosis.","volume":"52","author":"Tuyama","year":"2010","journal-title":"Hepatology"},{"key":"B154","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1002\/hep.26400","article-title":"Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients.","volume":"58","author":"Tyson","year":"2013","journal-title":"Hepatology"},{"key":"B155","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1086\/518796","article-title":"Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission.","volume":"196","author":"van de Laar","year":"2007","journal-title":"J. Infect. Dis."},{"key":"B156","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1111\/j.1572-0241.2001.04670.x","article-title":"High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial.","volume":"96","author":"Villa","year":"2001","journal-title":"Am. J. Gastroenterol."},{"key":"B157","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C.","volume":"38","author":"Wai","year":"2003","journal-title":"Hepatology"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1007\/s12325-015-0258-5","article-title":"Early view of the effectiveness of new direct-acting antiviral (DAA) regimens in patients with hepatitis C virus (HCV).","volume":"32","author":"Walker","year":"2015","journal-title":"Adv. Ther."},{"key":"B159","first-page":"131","article-title":"The aging population with HIV infection.","volume":"128","author":"Wing","year":"2017","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"B160","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/hep.1840190406","article-title":"Multiple viral infection as the most common cause of fulminant and subfulminant viral hepatitis in an area endemic for hepatitis B: application and limitations of the polymerase chain reaction.","volume":"19","author":"Wu","year":"1994","journal-title":"Hepatology"},{"key":"B161","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1056\/NEJMoa1503153","article-title":"Daclatasvir plus sofosbuvir for HCV in patients coinfected with HIV-1.","volume":"373","author":"Wyles","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"B162","first-page":"396","article-title":"Fibrosing cholestatic hepatitis: clinicopathologic spectrum, diagnosis and pathogenesis.","volume":"1","author":"Xiao","year":"2008","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"B163","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1155\/2005\/514813","article-title":"Acute coinfection with hepatitis B and hepatitis C viruses.","volume":"19","author":"Yan","year":"2005","journal-title":"Can. J. Gastroenterol."},{"key":"B164","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus.","volume":"1","author":"Yan","year":"2012","journal-title":"eLife"},{"key":"B165","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1136\/gut.47.6.845","article-title":"The natural history of HCV in a cohort of haemophilic patients infected between 1961 and 1985.","volume":"47","author":"Yee","year":"2000","journal-title":"Gut"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0102766","article-title":"Hepatitis C virus testing in adults living with HIV: a need for improved screening efforts.","volume":"9","author":"Yehia","year":"2014","journal-title":"PLoS One"},{"key":"B167","doi-asserted-by":"publisher","first-page":"S173","DOI":"10.1002\/hep.20956","article-title":"Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005.","volume":"43","author":"Yim","year":"2006","journal-title":"Hepatology"},{"key":"B168","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0168-8278(99)80383-3","article-title":"Mother-to-infant transmission of hepatitis C virus.","author":"Zanetti","year":"1999","journal-title":"J. Hepatol."},{"key":"B169","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/S1473-3099(14)70946-6","article-title":"HIV, hepatitis B virus, and hepatitis C virus co-infection in patients in the China National Free Antiretroviral Treatment Program, 2010-12: a retrospective observational cohort study.","volume":"14","author":"Zhang","year":"2014","journal-title":"Lancet Infect. Dis."}],"updated-by":[{"DOI":"10.3389\/fmicb.2023.1253124","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000}}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.780887\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T16:07:12Z","timestamp":1690906032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmicb.2021.780887\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,3]]},"references-count":169,"alternative-id":["10.3389\/fmicb.2021.780887"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2021.780887","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fmicb.2023.1253124","asserted-by":"object"}]},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,3]]},"article-number":"780887"}}